Skip to main content
. 2020 Aug 31;268(2):549–558. doi: 10.1007/s00415-020-10189-8

Table 2.

Vascular risk factors at baseline

Vascular risk factors NC (N = 84) MCI (N = 55) p value
Diabetes (H) 10 (12.2) 16 (29.1) 0.01
Hypercholesterolemia (H) 26 (31.7) 20 (36.3) 0.50
Hypertension (H) 46 (56.1%) 40 (72.73) 0.03
Hypertrigliceridemia (H) 9 (11.0) 11 (20.0) 0.12
SBP mmHg 127.5 ± 8.3 133.8 ± 16.9 0.01
DBP mmHg 76.0 ± 7.2 80.4 ± 10.0 0.01
SBP > 130 (median value) 30 (35.7) 27 (49.1) 0.1
SBP > 140 12 (14.3) 13 (23.6) 0.2
Antihypertensive drugs 44 (52.4) 39 (70.9) 0.03
HDL mg/dl 48.0 ± 11.8 49.5 ± 9.7 0.41
Total cholesterol mg/dl 180.2 ± 36.1 177.4 ± 32.7 0.6
Smoking 15 (19.7) 11 (20.3) 0.3
 Cigarette/diea 17.8 ± 11.7 16.6 ± 13.4 0.99
Atrial fibrillation 1 (1.2) 3(5.4) 0.1
FR Score (HVR) 58(69.0) 42 (75.4) 0.3
Myocardial infarction 9 (11.0) 6 (10.9) 0.9
Stroke 0 1(1.8) /
TIA 0 0 /
Average Wahlund 2.2 ± 2.8 3.3 ± 4.5 0.07
Wahlund score
 0 (score = 0) 39 (46.4) 26 (47.3)
 1 (score 1–4) 34(40.2) 9 (16.4)
 2 (score > 4) 11 (13.1) 20 (36.4)

Data presented are number (percentage %) for categorical and mean ± SD for continuous data. Significant results are expressed in bold

NC normal cognition, MCI mild cognitive impairment, H history, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high density lipoproteins, FR score HVR Framingam Risk Score, high vascular risk, TIA transient ischemic attack

aNumber of cigarette/day was available for 126 subjects